在MCL介质中培养的带衍生中酶体干细胞,用于治疗无塑性贫血
Chuan He1, Chao Yang2, Qiang Zeng1
1Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Stem cell research & therapy
|August 30, 2023
概括
来自带的介质干细胞 (MSC) 显示出治疗无塑性贫血 (AA) 的潜力. 在MCL介质中培养的MSCs在AA小鼠模型中有效支持血液形成和免疫调节.
科学领域:
- 干细胞生物学 干细胞生物学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 介质细胞干细胞 (MSCs) 具有自我更新和分化能力.
- 目前,MSC正在作为治疗无塑性贫血 (AA) 的潜在疗法进行研究.
研究的目的:
- 评估在不同介质中培养的带衍生MSCs在治疗无塑性贫血方面的疗效.
- 为了比较Mesencult-XF,MCL和StemPro MSC SFM CTS介质对MSC特征和治疗潜力的影响.
主要方法:
- 带衍生MSCs在三个不同的介质中培养.
- 使用ELISA分析了细胞因子 (HGF,PGE2,ANG-1,TGF-β1,IFN-γ,TNF-α) 的情况.
- 建立了一个无塑性贫血小鼠模型,并用MSCs治疗;血液学参数,VEGF和Tregs被监测.
主要成果:
- 所有测试的介质都支持MSC特征,MCL和StemPro显示了有益因子 (ANG-1,TGF-β1) 的增强分泌和炎症细胞因子 (IFN-γ,TNF-α) 的抑制.
- 在AA小鼠中,MSC治疗显著改善了周围血液细胞计数,增加了Treg比率和VEGF水平,并促进了骨髓恢复.
- 在MCL介质中培养的MSC显示出优异的血液形成支持和免疫调节.
结论:
- 在MCL介质中培养的MSCs有利于支持血液形成和调节免疫力.
- 在MCL介质中培养的带衍生MSC显示出有效治疗无塑性贫血的巨大潜力.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


